|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-11-5
|
|
pubmed:abstractText |
Cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites or recurrent variceal bleeding are at risk for decompensation and death. This study examined whether a new model for end stage liver disease (MELD), which incorporates serum sodium (MELDNa), is a better predictor of death or transplant after TIPS than the original MELD.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1542-7714
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1236-40
|
|
pubmed:dateRevised |
2011-4-29
|
|
pubmed:meshHeading |
pubmed-meshheading:19560557-Adult,
pubmed-meshheading:19560557-Female,
pubmed-meshheading:19560557-Humans,
pubmed-meshheading:19560557-Liver Failure,
pubmed-meshheading:19560557-Male,
pubmed-meshheading:19560557-Middle Aged,
pubmed-meshheading:19560557-Models, Statistical,
pubmed-meshheading:19560557-Portasystemic Shunt, Surgical,
pubmed-meshheading:19560557-Prognosis,
pubmed-meshheading:19560557-Retrospective Studies,
pubmed-meshheading:19560557-Serum,
pubmed-meshheading:19560557-Severity of Illness Index,
pubmed-meshheading:19560557-Sodium,
pubmed-meshheading:19560557-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt.
|
|
pubmed:affiliation |
Department of Medicine, Division of Gastroenterology, University of California, San Francisco, San Francisco, California, USA. jennifer.guy@ucsf.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
